TY - JOUR
T1 - Assessing fatigue and sleep in chronic diseases using physiological signals from wearables
T2 - A pilot study
AU - Antikainen, Emmi
AU - Njoum, Haneen
AU - on behalf of the IDEA-FAST project consortium
AU - Kudelka, Jennifer
AU - Branco, Diogo
AU - Rehman, Rana Zia Ur
AU - Macrae, Victoria
AU - Davies, Kristen
AU - Hildesheim, Hanna
AU - Emmert, Kirsten
AU - Reilmann, Ralf
AU - Janneke van der Woude, C.
AU - Maetzler, Walter
AU - Ng, Wan Fai
AU - O’Donnell, Patricio
AU - Van Gassen, Geert
AU - Baribaud, Frédéric
AU - Pandis, Ioannis
AU - Manyakov, Nikolay V.
AU - van Gils, Mark
AU - Ahmaniemi, Teemu
AU - Chatterjee, Meenakshi
N1 - Funding Information:
The presented work was funded via the IDEA-FAST project, which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 853981. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and associated partners.
Publisher Copyright:
Copyright © 2022 Antikainen, Njoum, Kudelka, Branco, Rehman, Macrae, Davies, Hildesheim, Emmert, Reilmann, Janneke van der Woude, Maetzler, Ng, O’Donnell, Van Gassen, Baribaud, Pandis, Manyakov, van Gils, Ahmaniemi and Chatterjee.
PY - 2022/11/14
Y1 - 2022/11/14
N2 - Problems with fatigue and sleep are highly prevalent in patients with chronic diseases and often rated among the most disabling symptoms, impairing their activities of daily living and the health-related quality of life (HRQoL). Currently, they are evaluated primarily via Patient Reported Outcomes (PROs), which can suffer from recall biases and have limited sensitivity to temporal variations. Objective measurements from wearable sensors allow to reliably quantify disease state, changes in the HRQoL, and evaluate therapeutic outcomes. This work investigates the feasibility of capturing continuous physiological signals from an electrocardiography-based wearable device for remote monitoring of fatigue and sleep and quantifies the relationship of objective digital measures to self-reported fatigue and sleep disturbances. 136 individuals were followed for a total of 1,297 recording days in a longitudinal multi-site study conducted in free-living settings and registered with the German Clinical Trial Registry (DRKS00021693). Participants comprised healthy individuals (N = 39) and patients with neurodegenerative disorders (NDD, N = 31) and immune mediated inflammatory diseases (IMID, N = 66). Objective physiological measures correlated with fatigue and sleep PROs, while demonstrating reasonable signal quality. Furthermore, analysis of heart rate recovery estimated during activities of daily living showed significant differences between healthy and patient groups. This work underscores the promise and sensitivity of novel digital measures from multimodal sensor time-series to differentiate chronic patients from healthy individuals and monitor their HRQoL. The presented work provides clinicians with realistic insights of continuous at home patient monitoring and its practical value in quantitative assessment of fatigue and sleep, an area of unmet need.
AB - Problems with fatigue and sleep are highly prevalent in patients with chronic diseases and often rated among the most disabling symptoms, impairing their activities of daily living and the health-related quality of life (HRQoL). Currently, they are evaluated primarily via Patient Reported Outcomes (PROs), which can suffer from recall biases and have limited sensitivity to temporal variations. Objective measurements from wearable sensors allow to reliably quantify disease state, changes in the HRQoL, and evaluate therapeutic outcomes. This work investigates the feasibility of capturing continuous physiological signals from an electrocardiography-based wearable device for remote monitoring of fatigue and sleep and quantifies the relationship of objective digital measures to self-reported fatigue and sleep disturbances. 136 individuals were followed for a total of 1,297 recording days in a longitudinal multi-site study conducted in free-living settings and registered with the German Clinical Trial Registry (DRKS00021693). Participants comprised healthy individuals (N = 39) and patients with neurodegenerative disorders (NDD, N = 31) and immune mediated inflammatory diseases (IMID, N = 66). Objective physiological measures correlated with fatigue and sleep PROs, while demonstrating reasonable signal quality. Furthermore, analysis of heart rate recovery estimated during activities of daily living showed significant differences between healthy and patient groups. This work underscores the promise and sensitivity of novel digital measures from multimodal sensor time-series to differentiate chronic patients from healthy individuals and monitor their HRQoL. The presented work provides clinicians with realistic insights of continuous at home patient monitoring and its practical value in quantitative assessment of fatigue and sleep, an area of unmet need.
UR - http://www.scopus.com/inward/record.url?scp=85142922378&partnerID=8YFLogxK
U2 - 10.3389/fphys.2022.968185
DO - 10.3389/fphys.2022.968185
M3 - Article
C2 - 36452041
AN - SCOPUS:85142922378
SN - 1664-042X
VL - 13
JO - Frontiers in Physiology
JF - Frontiers in Physiology
M1 - 968185
ER -